Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue

Basic Research in Cardiology

Volumn 108, Issue 3, 2013, Pages

  Crocini, Claudia ^a,b   Arimura, Takuro ^c   Reischmann, Silke ^a,b   Eder, Alexandra ^a,b   Braren, Ingke ^a,b   Hansen, Arne ^a,b   Eschenhagen, Thomas ^a,b   Kimura, Akinori ^c   Carrier, Lucie ^a,b,d,e  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d INSERM   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

ANKRD1; Engineered heart tissue; Hypertrophic cardiomyopathy; Sarcomere

Indexed keywords

ANKYRIN REPEAT DOMAIN 1 PROTEIN; EPOXOMICIN; PARVOVIRUS VECTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANKRD1 GENE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENGINEERED HEART TISSUE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSDUCTION; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOFLUORESCENCE; MUTANT; NEWBORN; NONHUMAN; PLASMID; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMERE; TISSUE ENGINEERING; WILD TYPE;

EID: 84875858010     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0349-x     Document Type: Article

References (50)

1. Ahmad F, Seidman JG, Seidman CE (2005) The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet 6:185-216. doi: 10.1146/annurev.genom.6. 080604.162132
2. Aihara Y, Kurabayashi M, Saito Y, Ohyama Y, Tanaka T, Takeda S, Tomaru K, Sekiguchi K, Arai M, Nakamura T, Nagai R (2000) Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension 36:48-53
3. Arimura T, Bos JM, Sato A, Kubo T, Okamoto H, Nishi H, Harada H, Koga Y, Moulik M, Doi YL, Towbin JA, Ackerman MJ, Kimura A (2009) Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J Am Coll Cardiol 54:334-342. doi: 10.1016/j.jacc.2008.12.082
4. Badi I, Cinquetti R, Frascoli M, Parolini C, Chiesa G, Taramelli R, Acquati F (2009) Intracellular ANKRD1 protein levels are regulated by 26S proteasome-mediated degradation. FEBS Lett 583:2486-2492. doi: 10.1016/j.febslet.2009.07.001
5. Bang ML, Mudry RE, McElhinny AS, Trombitas K, Geach AJ, Yamasaki R, Sorimachi H, Granzier H, Gregorio CC, Labeit S (2001) Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies. J Cell Biol 153:413-427
6. Barash IA, Bang ML, Mathew L, Greaser ML, Chen J, Lieber RL (2007) Structural and regulatory roles of muscle ankyrin repeat protein family in skeletal muscle. Am J Physiol Cell Physiol 293:C218-C227. doi: 10.1152/ajpcell.00055.2007
7. Barefield D, Sadayappan S (2010) Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol 48:866-875. doi: 10.1016/j.yjmcc.2009.11.014
8. Baudet S (2003) Another activity for the cardiac biologist: CARP fishing. Cardiovasc Res 59:529-531 ([pii] S0008636303005030)
9. Cazorla O, Szilagyi S, Vignier N, Salazar G, Kramer E, Vassort G, Carrier L, Lacampagne A (2006) Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res 69:370-380. doi: 10.1016/j.cardiores.2005.11.009
10. Chen B, Zhong L, Roush SF, Pentassuglia L, Peng X, Samaras S, Davidson JM, Sawyer DB, Lim CC (2012) Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy. PLoS ONE 7:e35743. doi: 10.1371/journal.pone.0035743
11. Cinquetti R, Badi I, Campione M, Bortoletto E, Chiesa G, Parolini C, Camesasca C, Russo A, Taramelli R, Acquati F (2008) Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return. Hum Mutat 29:468-474. doi: 10.1002/humu.20711
12. Fraysse B, Weinberger F, Bardswell SC, Cuello F, Vignier N, Geertz B, Starbatty J, Kramer E, Coirault C, Eschenhagen T, Kentish JC, Avkiran M, Carrier L (2012) Increased myofilament Ca(2+) sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol 52:1299-1307. doi: 10.1016/j.yjmcc.2012.03.009
13. Friedrich FW, Carrier L (2012) Genetics of hypertrophic and dilated cardiomyopathy. Curr Pharm Biotechnol 13:2467-2476 ([pii] CPB-EPUB-20120120-006)
14. Friedrich FW, Wilding BR, Reischmann S, Crocini C, Lang P, Charron P, Muller OJ, McGrath MJ, Vollert I, Hansen A, Linke WA, Hengstenberg C, Bonne G, Morner S, Wichter T, Madeira H, Arbustini E, Eschenhagen T, Mitchell CA, Isnard R, Carrier L (2012) Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum Mol Genet 21:3237-3254. doi: 10.1093/hmg/dds157
15. Hansen A, Eder A, Bonstrup M, Flato M, Mewe M, Schaaf S, Aksehirlioglu B, Schwoerer AP, Uebeler J, Eschenhagen T (2010) Development of a drug screening platform based on engineered heart tissue. Circ Res 107:35-44. doi: 10.1161/CIRCRESAHA.109.211458
16. Hirt MN, Sorensen NA, Bartholdt LM, Boeddinghaus J, Schaaf S, Eder A, Vollert I, Stohr A, Schulze T, Witten A, Stoll M, Hansen A, Eschenhagen T (2012) Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Res Cardiol 107:307. doi: 10.1007/s00395-012-0307-z
17. Ihara Y, Suzuki YJ, Kitta K, Jones LR, Ikeda T (2002) Modulation of gene expression in transgenic mouse hearts overexpressing calsequestrin. Cell Calcium 32:21-29 ([pii] S0143416002000969)
18. Jeyaseelan R, Poizat C, Baker RK, Abdishoo S, Isterabadi LB, Lyons GE, Kedes L (1997) A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J Biol Chem 272:22800-22808
19. Kimura A (2010) Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond. J Hum Genet 55:81-90. doi: 10.1038/jhg.2009.138
20. Kuo H, Chen J, Ruiz-Lozano P, Zou Y, Nemer M, Chien KR (1999) Control of segmental expression of the cardiac-restricted ankyrin repeat protein gene by distinct regulatory pathways in murine cardiogenesis. Development 126:4223-4234
21. Laure L, Daniele N, Suel L, Marchand S, Aubert S, Bourg N, Roudaut C, Duguez S, Bartoli M, Richard I (2010) A new pathway encompassing calpain 3 and its newly identified substrate cardiac ankyrin repeat protein is involved in the regulation of the nuclear factor-kappaB pathway in skeletal muscle. FEBS J 277:4322-4337. doi: 10.1111/j.1742-4658.2010.07820.x
22. Linke WA (2008) Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res 77:637-648. doi: 10.1016/j.cardiores.2007.03.029
23. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807-1816. doi: 10.1161/CIRCULATIONAHA.106.174287
24. Mikhailov AT, Torrado M (2008) The enigmatic role of the ankyrin repeat domain 1 gene in heart development and disease. Int J Dev Biol 52:811-821. doi: 10.1387/ijdb.082655am
25. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, Granzier H, McElhinny AS, Gregorio CC, Labeit S (2003) The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J Mol Biol 333:951-964 ([pii] S0022283603011380)
26. Morimoto S, Yanaga F, Minakami R, Ohtsuki I (1998) Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol 275:C200-C207
27. Moulik M, Vatta M, Witt SH, Arola AM, Murphy RT, McKenna WJ, Boriek AM, Oka K, Labeit S, Bowles NE, Arimura T, Kimura A, Towbin JA (2009) ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. J Am Coll Cardiol 54:325-333. doi: 10.1016/j.jacc.2009.02.076
28. Muller OJ, Schinkel S, Kleinschmidt JA, Katus HA, Bekeredjian R (2008) Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther 15:1558-1565. doi: 10.1038/gt.2008.111
29. Neulen A, Stehle R, Pfitzer G (2009) The cardiac troponin C mutation Leu29Gln found in a patient with hypertrophic cardiomyopathy does not alter contractile parameters in skinned murine myocardium. Basic Res Cardiol 104:751-760. doi: 10.1007/s00395-009-0038-y
30. Pohlmann L, Kroger I, Vignier N, Schlossarek S, Kramer E, Coirault C, Sultan KR, El-Armouche A, Winegrad S, Eschenhagen T, Carrier L (2007) Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res 101:928-938. doi: 10.1161/CIRCRESAHA.107.158774
31. Predmore JM, Wang P, Davis F, Bartolone S, Westfall MV, Dyke DB, Pagani F, Powell SR, Day SM (2010) Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 121:997-1004. doi: 10.1161/CIRCULATIONAHA.109.904557
32. Purevjav E, Arimura T, Augustin S, Huby AC, Takagi K, Nunoda S, Kearney DL, Taylor MD, Terasaki F, Bos JM, Ommen SR, Shibata H, Takahashi M, Itoh-Satoh M, McKenna WJ, Murphy RT, Labeit S, Yamanaka Y, Machida N, Park JE, Alexander PM, Weintraub RG, Kitaura Y, Ackerman MJ, Kimura A, Towbin JA (2012) Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations. Hum Mol Genet 21:2039-2053. doi: 10.1093/hmg/dds022
33. Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21:267-271 ([pii] S0968-0004(96)10031-1)
34. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93:841-842
35. Robinson P, Griffiths PJ, Watkins H, Redwood CS (2007) Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments. Circ Res 101:1266-1273
36. Samaras SE, Chen B, Koch SR, Sawyer DB, Lim CC, Davidson JM (2012) 26S proteasome regulation of Ankrd1/CARP in adult rat ventricular myocytes and human microvascular endothelial cells. Biochem Biophys Res Commun 425:830-835. doi: 10.1016/j.bbrc.2012.07.162
37. Schlossarek S, Englmann DR, Sultan KR, Sauer M, Eschenhagen T, Carrier L (2012) Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy. Basic Res Cardiol 107:235. doi: 10.1007/s00395-011-0235-3
38. Schlossarek S, Mearini G, Carrier L (2011) Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities. J Mol Cell Cardiol 50:613-620. doi: 10.1016/j.yjmcc.2011.01.014
39. Schlossarek S, Schuermann F, Geertz B, Mearini G, Eschenhagen T, Carrier L (2012) Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice. J Muscle Res Cell Motil 33:5-15. doi: 10.1007/s10974-011-9273-6
40. Tripathi S, Schultz I, Becker E, Montag J, Borchert B, Francino A, Navarro-Lopez F, Perrot A, Ozcelik C, Osterziel KJ, McKenna WJ, Brenner B, Kraft T (2011) Unequal allelic expression of wild-type and mutated beta-myosin in familial hypertrophic cardiomyopathy. Basic Res Cardiol 106:1041-1055. doi: 10.1007/s00395-011-0205-9
41. Tsukamoto O, Minamino T, Kitakaze M (2010) Functional alterations of cardiac proteasomes under physiological and pathological conditions. Cardiovasc Res 85:339-346. doi: 10.1093/cvr/cvp282
42. van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stienen GJ, van der Velden J (2009) Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 119:1473-1483. doi: 10.1161/CIRCULATIONAHA.108.838672
43. van Dijk SJ, Paalberends ER, Najafi A, Michels M, Sadayappan S, Carrier L, Boontje NM, Kuster DW, van Slegtenhorst M, Dooijes D, Dos Remedios C, Ten Cate FJ, Stienen GJ, van der Velden J (2012) Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function. Circ Heart Fail 5:36-46. doi: 10.1161/ CIRCHEARTFAILURE.111.963702
44. Vandenburgh H, Shansky J, Benesch-Lee F, Barbata V, Reid J, Thorrez L, Valentini R, Crawford G (2008) Drug-screening platform based on the contractility of tissue-engineered muscle. Muscle Nerve 37:438-447. doi: 10.1002/mus.20931
45. Vignier N, Schlossarek S, Fraysse B, Mearini G, Kramer E, Pointu H, Mougenot N, Guiard J, Reimer R, Hohenberg H, Schwartz K, Vernet M, Eschenhagen T, Carrier L (2009) Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice. Circ Res 105:239-248. doi: 10.1161/CIRCRESAHA.109.201251
46. Witt CC, Witt SH, Lerche S, Labeit D, Back W, Labeit S (2008) Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J 27:350-360. doi: 10.1038/sj.emboj.7601952
47. Witt SH, Labeit D, Granzier H, Labeit S, Witt CC (2005) Dimerization of the cardiac ankyrin protein CARP: implications for MARP titin-based signaling. J Muscle Res Cell Motil 26:401-408. doi: 10.1007/s10974-005-9022-9
48. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T (2000) Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68:106-114. doi: 10.1002/(SICI)1097-0290(20000405) 68:1<106::AID-BIT13>3.0.CO;2-3
49. Zolk O, Frohme M, Maurer A, Kluxen FW, Hentsch B, Zubakov D, Hoheisel JD, Zucker IH, Pepe S, Eschenhagen T (2002) Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 293:1377-1382. doi: 10.1016/S0006-291X(02) 00387-X
50. Zou Y, Evans S, Chen J, Kuo HC, Harvey RP, Chien KR (1997) CARP, a cardiac ankyrin repeat protein, is downstream in the Nk2-5 homeobox gene pathway. Development 124:793-804